Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
Department of Health and Human Services
The Blueprint Neurotherapeutics Network (BPN) invites applications from neuroscience investigators seeking support to advance their small molecule drug discovery and development projects into the clinic. Participants in the BPN are responsible for conducting all studies that involve disease- or target-specific assays, models, and other research tools and receive funding for all activities to be conducted in their own laboratories. In addition, applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract research organizations (CROs) that specialize in medicinal chemistry, pharmacokinetics, toxicology, formulations development, chemical synthesis inc
Funding
Award size
Not specified
Type
Cooperative Agreement
Dates
Deadline
Closing this month
Posted
09/25/2024
Closes
2026-08-18
Eligibility
Eligibility
County governmentsState governmentsNative American tribal governments (Federally recognized)Small businessesPublic housing authorities/Indian housing authoritiesNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationFor profit organizations other than small businessesNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationOthers (see text field entitled "Additional Information on Eligibility" for clarification)Independent school districtsCity or township governmentsSpecial district governmentsNative American tribal organizations (other than Federally recognized tribal governments)Public and State controlled institutions of higher educationPrivate institutions of higher education
Program
Funding area
Education - EDHealth - HL
Opportunity #
PAR-25-051
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov